文献速递临床试验与 GCP

早期微创影像引导内镜清除脑出血(EMINENT-ICH):一项随机对照试验

Early minimally invasive image-guided endoscopic evacuation of intracerebral hemorrhage (EMINENT-ICH): a randomized controlled trial.
PubMed 文献 · Trials · 2024-10-18

本研究为前瞻性、平行组、结局评估者盲法的多中心随机对照试验,在瑞士开展,将早期微创内镜手术与最佳药物治疗按1:1随机分组比较,主要结局为6个月后功能结局改善(mRS<3),旨在为自发性幕上脑出血提供I级证据。

要点

  • 自发性幕上脑出血病死率超过50%,目前缺乏足够有效的改善死亡率和功能结局的治疗。
  • 微创手术尤其是内镜手术可能改善生存率和功能结局,但缺乏大型验证性研究。
  • 本试验为前瞻性、平行组、结局评估者盲法多中心随机对照试验,比较早期内镜手术与最佳药物治疗。

核心结论

  • 本试验将比较早期微创内镜手术是否较最佳药物治疗改善功能结局率。
  • 该试验可为未来脑出血治疗选择提供I级证据。

研究设计与样本

  • 前瞻性、平行组、结局评估者盲法的多中心随机对照试验,在瑞士开展。
  • 将内镜手术与最佳药物治疗按1:1随机分组比较,总研究时长12个月。
  • 主要结局定义为6个月后功能结局改善(mRS<3)。
  • 次要结局包括死亡率和并发症率、患者报告结局以及脑损伤血清生物标志物的时间演变。

主要发现

  • 自发性幕上脑出血病死率超过50%。
  • 目前缺乏足够有效的改善死亡率和功能结局率的治疗。
  • 微创手术尤其是内镜手术可能改善生存率和功能结局率,但缺乏大型验证性研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 本试验可能面临患者入组、对所用血肿清除技术的依从性、潜在的患者交叉以及适应性贝叶斯统计设计等实际和方法学问题。
  • 目前缺乏评估早期内镜手术在脑出血中作用和潜在效应的大型随机试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spontaneous supratentorial intracerebral hemorrhage is the deadliest form of stroke with mortality rates over 50%. Currently, no sufficiently effective treatment to improve both mortality and functional outcome rates exists. However, it seems that minimally invasive surgery, especially endoscopic surgery, might be beneficial in improving survival and functional outcome rates, yet large confirmatory studies thereof are lacking. The aim of this trial is to compare whether early minimally invasive endoscopic surgery leads to improved functional outcome rates compared to the best medical treatment. METHODS: This is a prospective, parallel-arm, outcome assessor blinded multicenter trial across Switzerland. Endoscopic surgery will be compared to the best medical treatment in a 1:1 randomization over a total time of 12 months. The primary outcome is defined as improved functional outcome (mRS < 3) after 6 months; secondary outcomes include mortality and morbidity rates as well as patient reported outcomes and the temporal evolution of serum biomarkers for brain damage. DISCUSSION: Currently, large, randomized trials assessing the role and potential effect of early endoscopic surgery in intracerebral hemorrhage are lacking. Potential practical and methodological issues faced in this trial are patient enrollment, adherence to the hematoma evacuation technique used, potential patient cross-over, and the adaptive Bayesian statistical design. Nonetheless, this trial would be among the first to research the effects of early minimally invasive endoscopic surgery for SSICH and can provide class I evidence for future treatment options in intracerebral hemorrhage. TRIAL REGISTRATION: ClinicalTrials.gov NCT05681988. Registered on January 3, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hallenberger TJ, Fischer U, Bonati LH, et al. Early minimally invasive image-guided endoscopic evacuation of intracerebral hemorrhage (EMINENT-ICH): a randomized controlled trial. Trials. 2024. PMID: 39425219. doi:10.1186/s13063-024-08534-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。